Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Novosteo logo — Innovative solutions for bone recovery and health, accelerat...

Novosteo

Innovative solutions for bone recovery and health, accelerating healing with precision-targeted treatments.

Founded 2017 Series A Total: $7.95M Biotechnology, Health Care +1

General Information

Company Name Novosteo
Founded Year 2017
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Novosteo. To contact Novosteo, visit novosteo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Novosteo compare?

A PDF of Novosteo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Novosteo soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Novosteo

Novosteo is a biotechnology startup founded in 2017 with a mission to revolutionize bone recovery and health. The company's innovative solutions focus on accelerating healing with precision-targeted treatments. Utilizing a unique chemistry method for bone targeting and discovering new biologics, Novosteo aims to address issues related to patients' morbidity, mortality, and loss of mobility and productivity due to bone fractures, bone metastasis, and infections. The scientific co-founders, Stewart Low and Philip Low from Purdue University, have spearheaded the development of medications that speed up bone regeneration by delivering anabolic agents specifically to fracture surfaces. In January 2021, Novosteo secured a significant $5.50M Series A investment from prominent investors including Elevate Ventures, Kairos Ventures, BioCrossroads, and the Purdue Research Foundation. This funding injection not only validates the potential of Novosteo's groundbreaking approach but also provides the necessary resources to drive further research and development initiatives. As Novosteo continues to make strides in the biotechnology, healthcare, and pharmaceutical industries, its innovative solutions hold promise for transforming the treatment of bone injuries and diseases, ultimately improving patient outcomes and quality of life.

Business keywords: bone recovery, precision-targeted treatments, medications, bone injuries, bone diseases, fracture treatment, biologics, bone regeneration, anabolic agents, precision medicine, biomedical technology, scientific research, startup, medical advancements

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $5.50M 4
Elevate Ventures Kairos Ventures BioCrossroads
Elevate Ventures, Kairos Ventures +2
13 Jan 2021
Seed Round $500.00K 1
Research Bridge Partners
Research Bridge Partners
09 Aug 2019
Pre Seed Round $250.00K 1
Purdue Research Foundation
20 Dec 2018
Grant $1.70M 1
National Institutes of Health
27 Sep 2018

Novosteo Alternatives & Competitors

View All Alternatives
Novosteo vs
Novo Biosciences
Novo Biosciences

Innovative cardiac treatments reviving the body's own healing powers to regenerate heart tissue and...

Venture round
Biotechnology, Health Care
Novosteo vs
Visterra Inc.
Visterra Inc. United States

We bring better biologics to life. Biospace Best Place to Work 2024!

Series C
139 employees
Biotechnology, Health Care
Novosteo vs
Korro Bio, Inc.
Korro Bio, Inc. United States

Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine.

IPO
75 employees
Biotechnology, Health Care
View all alternatives

FAQ About Novosteo

Innovative solutions for bone recovery and health, accelerating healing with precision-targeted treatments.
Novosteo was founded in 2017.
Novosteo operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on bone recovery, precision-targeted treatments, medications and bone injuries.
Novosteo has completed 4 funding rounds, raising a total of $7.95M. The latest funding stage is Series A.
Top alternatives and competitors to Novosteo include Novo Biosciences, Visterra Inc., Korro Bio, Inc., Alivio Therapeutics, CryptoMedix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Novosteo and Novo Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Novosteo, https://bouncewatch.com/company/novosteo, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes